Skip to content
BOLUS

Signal from the log

GenHealth.ai

16,5 M$ · Series A · United States · Health software

GenHealth.ai déploie des agents logiciels qui exécutent seuls les tâches du back office médical américain : admission, vérification des droits, accord préalable, facturation, rejets et recours. La société est née en 2023 d'un essaimage de 1upHealth et dit avoir levé 30 M$ au total. Les gains annoncés, 34 % de recettes en plus et jusqu'à 80 % de coûts administratifs en moins, sont des chiffres d'exploitant.

Verified

Announced on , logged by the watch of 11 September 2026.

Operation
Funding round
Announced amount
16,5 M$
Stage
Series A
Country
United States
Sector
Health software

What the log says

Editorial note, in French

Communiqué ouvert, montant relu et fonds nommés.

The investors

Led by Flare Capital Partners , with Craft , Obvious Ventures , Eniac Ventures , InHealth Ventures , Epsilon Health Investors , ARTIS

Provenance
Source medcity
Logged on 11 September 2026
Description Written in French during the watch run. Written during the watch run, after reading the issuer's press release or the source article.
Verification Amounts and fund names were double checked against the issuer's press release or an official filing.
What this status means
Verified The press release was opened: amount double checked, funds named. The article remains to be written.
The rule A signal is never removed from the log. A round set aside stays readable with its reason, because a collection you cannot reread is a collection you cannot correct.

One address, nothing else.

One letter a week, on Fridays: the week's funding rounds, the funds named, the amounts double checked. The list is never sold, one click to unsubscribe. The letter is written in French.

Email confirmation before any subscription. The list is never sold. What Bolus knows about you is written on the privacy page (in French).